Lu WJ - Search Results

1

Enucleation of non-invasive tumors in the proximal pancreas: indications and outcomes compared with standard resections.

Lu WJ, Cai HL, Ye MD, Wu YL, Xu B. Lu WJ, et al. J Zhejiang Univ Sci B. 2017 Oct.;18(10):906-916. doi: 10.1631/jzus.B1600597. J Zhejiang Univ Sci B. 2017. PMID: 28990381 Free PMC article.

2

DJ-1, a novel biomarker and a selected target gene for overcoming chemoresistance in pancreatic cancer.

Chen Y, Kang M, Lu W, Guo Q, Zhang B, Xie Q, Wu Y. Chen Y, et al. J Cancer Res Clin Oncol. 2012 Sep;138(9):1463-74. doi: 10.1007/s00432-012-1205-3. Epub 2012 Apr 19. J Cancer Res Clin Oncol. 2012. PMID: 22526154

3

Delta like ligand 4 induces impaired chemo-drug delivery and enhanced chemoresistance in pancreatic cancer.

Kang M, Jiang B, Xu B, Lu W, Guo Q, Xie Q, Zhang B, Dong X, Chen D, Wu Y. Kang M, et al. Cancer Lett. 2013 Mar 1;330(1):11-21. doi: 10.1016/j.canlet.2012.11.015. Epub 2012 Nov 27. Cancer Lett. 2013. PMID: 23200678

4

MACC1: A potential molecule associated with pancreatic cancer metastasis and chemoresistance.

Wang G, Kang MX, Lu WJ, Chen Y, Zhang B, Wu YL. Wang G, et al. Among authors: lu wj. Oncol Lett. 2012 Oct;4(4):783-791. doi: 10.3892/ol.2012.784. Epub 2012 Jul 2. Oncol Lett. 2012. PMID: 23205101 Free PMC article.

5

Neoadjuvant therapy for patients with borderline resectable pancreatic cancer: A systematic review and meta-analysis of response and resection percentages.

Tang K, Lu W, Qin W, Wu Y. Tang K, et al. Pancreatology. 2016 Jan-Feb;16(1):28-37. doi: 10.1016/j.pan.2015.11.007. Epub 2015 Dec 2. Pancreatology. 2016. PMID: 26687001 Review.

6

VNN1, a potential biomarker for pancreatic cancer-associated new-onset diabetes, aggravates paraneoplastic islet dysfunction by increasing oxidative stress.

Kang M, Qin W, Buya M, Dong X, Zheng W, Lu W, Chen J, Guo Q, Wu Y. Kang M, et al. Cancer Lett. 2016 Apr 10;373(2):241-50. doi: 10.1016/j.canlet.2015.12.031. Epub 2016 Feb 1. Cancer Lett. 2016. PMID: 26845448

7

Thymidylate synthase prompts metastatic progression through the dTMP associated EMT process in pancreatic ductal adenocarcinoma.

Kang M, Zheng W, Chen Q, Qin W, Li P, Huang S, Zhou Y, Wang L, Cai H, Lu W, Jiang B, Guo Q, Chen J, Wan D, Rao J, Wu Y. Kang M, et al. Cancer Lett. 2018 Apr 10;419:40-52. doi: 10.1016/j.canlet.2018.01.026. Epub 2018 Jan 11. Cancer Lett. 2018. PMID: 29331423

8

E74-like ETS transcription factor 1 promotes the progression of pancreatic cancer by regulating doublecortin-like kinase 1/Janus kinase/signal transducer and activator of transcription pathway.

Yang B, Shen F, Zhu Y, Lu W, Cai H. Yang B, et al. Am J Cancer Res. 2024 Feb 15;14(2):616-629. doi: 10.62347/TEWF1767. eCollection 2024. Am J Cancer Res. 2024. PMID: 38455425 Free PMC article.

9

Sequential therapy for pancreatic cancer patients with synchronous oligo-hepatic metastatic lesions.

Lu W, Wang L, Lou J, Tang K. Lu W, et al. Tumori. 2023 Jun;109(3):307-313. doi: 10.1177/03008916221110265. Epub 2022 Jul 10. Tumori. 2023. PMID: 35815545

10

Efficacy and safety of FOLFIRINOX as second-line chemotherapy for advanced pancreatic cancer after gemcitabine-based therapy: A systematic review and meta-analysis.

Lu W, Wang L, Li X, Tang K. Lu W, et al. J Int Med Res. 2022 Apr;50(4):3000605221093225. doi: 10.1177/03000605221093225. J Int Med Res. 2022. PMID: 35481414 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

465 results

Search Page

Filters